Steris (STE) EBIT (2018 - 2026)

Steris' EBIT history runs 9 years deep, the most recent figure standing at $316.8 million for Q1 2026.

• In Q1 2026, EBIT rose 46.6% year-over-year to $316.8 million; the TTM figure through Mar 2026 stood at $1.1 billion (up 27.14% YoY), while the FY2026 annual figure was $1.1 billion, up 27.14% from the prior year.
• EBIT was $316.8 million for Q1 2026 at Steris, up from $273.2 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $748.3 million in Q1 2023 to a low of -$306.4 million in Q3 2022.
• Historically, EBIT has averaged $220.0 million across 5 years, with a median of $219.7 million in 2024.
• Biggest YoY gain for EBIT was 1005.8% in 2022; the steepest drop was 363.01% in 2022.
• A 5-year view of EBIT shows it stood at $190.8 million in 2022, then rose by 18.69% to $226.5 million in 2023, then advanced by 8.31% to $245.3 million in 2024, then rose by 11.37% to $273.2 million in 2025, then climbed by 15.96% to $316.8 million in 2026.
• The last three EBIT figures came in at $316.8 million (Q1 2026), $273.2 million (Q4 2025), and $265.8 million (Q3 2025), per Business Quant data.